| Literature DB >> 32539395 |
Paulina Spisz1, Magdalena Zdrowowicz1, Witold Kozak1, Lidia Chomicz-Mańka1, Karina Falkiewicz1, Samanta Makurat1, Artur Sikorski2, Dariusz Wyrzykowski3, Janusz Rak1, Eugene Arthur-Baidoo4, Patrick Ziegler4, Mateus Salomao Rodrigues Costa4, Stephan Denifl4.
Abstract
Efficient radiotherapy requires the concomitant use of ionizing radiation (IR) and a radiosensitizer. In the present work uracil-5-yl O-sulfamate (Entities:
Mesh:
Substances:
Year: 2020 PMID: 32539395 PMCID: PMC7356320 DOI: 10.1021/acs.jpcb.0c03844
Source DB: PubMed Journal: J Phys Chem B ISSN: 1520-5207 Impact factor: 2.991
Summary of the Resonance Positions, Experimental Thresholds, and Calculated Thermodynamic Thresholds for the Fragment Anions Formed upon Electron Attachment to Uracil-5-yl O-Sulfamate
| threshold (eV) at 1.58 × 10–11 atm | ||||||||
|---|---|---|---|---|---|---|---|---|
| maxima
of peak positions (eV) | calcd | |||||||
| mass | anion | 1 | 2 | 3 | 4 | expt 430.15 K | 298.15 K | 430.15 K |
| 127 | C4H3N2O3 | ∼0 | 0.2 | 1.5 | – | ∼0 | –0.36 | –0.90 |
| 126 | C4H2N2O3 | ∼0 | 0.1 | 0.2 | 1.2 | ∼0 | –0.25 | –0.78 |
| 99 | C3H3N2O2 | 0.1 | 0.8 | – | – | ∼0 | –0.66 | –1.70 |
| 96 | NH2SO3 | ∼0 | 0.3 | 1.3 | – | ∼0 | –0.12 | –0.65 |
| 95 | NHSO3 | ∼0 | 0.2 | – | – | ∼0 | –0.89 | –1.41 |
| 86 | C2H2N2O2 | 0.1 | 0.3 | 0.9 | – | ∼0 | – | – |
| 80 | NH2SO2 | ∼0 | – | – | – | ∼0 | –0.79 | –1.33 |
| SO3 | ∼0 | –1.76 | –2.29 | |||||
| 64 | SO2 | 1.1 | 5.8 | – | – | ∼0 | 0.09 | –0.45 |
| 62 | NSO | 0.6 | 0.8 | – | – | ∼0.3 | –0.98 | –2.01 |
| 48 | NH2O2 | 5.0 | 5.4 | – | – | ∼4.5 | 3.84 | 3.31 |
| 42 | OCN | ∼0 | 0.4 | 1.3 | – | ∼0 | – | – |
| 16 | NH2 | 4.9 | 8.3 | 11.6 | – | ∼4 | 2.63 | 2.11 |
| O | ∼4 | 2.86 | 2.40 | |||||
Figure 1DEA profile calculated for uracil-5-yl O-sulfamate at the M06-2X/6-31++G(d,p) level in an aqueous solution.
Figure 2Synthesis of uracil-5-yl O-sulfamate.
Figure 3Molecular structure of uracil-5-yl O-sulfamate, showing the atom-labeling scheme. Displacement ellipsoids are drawn at the 25% probability level, and H atoms are shown as small spheres of arbitrary radius.
Figure 4Crystal packing of uracil-5-yl O-sulfamate viewed along the a-axis. Hydrogen bonds are represented by dashed lines.
Figure 5Anion efficiency curve as a function of electron energy for the fragment anions NH2SO3– at m/z 96 and NHSO3– at m/z 95 upon electron attachment to uracil-5-yl O-sulfamate.
Figure 10Anion efficiency curves as a function of electron energies for anions at m/z 99, m/z 86, and m/z 42 upon electron attachment to uracil-5-yl O-sulfamate.
Figure 6Anion efficiency curves as functions of electron energies for the fragment anions observed at m/z 126, 127, and 80 formed from the single S–O bond cleavage upon electron attachment to uracil-5-yl O-sulfamate.
Figure 7Anion efficiency curves as functions of electron energies for the fragment anions formed at m/z 64 and 48 upon electron attachment to uracil-5-yl O-sulfamate.
Figure 8Anion efficiency curve of the fragment anion observed at m/z 62 as a function of electron energy upon electron attachment to uracil-5-yl O-sulfamate.
Figure 9Anion efficiency curve as a function of electron energy for the fragment anion observed at m/z 16 upon electron attachment to uracil-5-yl sulfamate.
Figure 11HPLC traces for a solution of uracil-5-yl O-sulfamate before (black) and after irradiation (orange) with a dose of 140 Gy.
Figure 12HPLC traces for a solution containing uracil-5-yl O-sulfamate and 5-bromouracil before (black chromatogram) and after irradiation with a dose of 140 Gy (orange chromatogram).
Figure 13Proton dissociation scheme for uracil-5-yl O-sulfamate.
Figure 14Concentration distribution of species as a function of pH in uracil-5-yl O-sulfamate solution.
Figure 15Structures of uracil derivatives along with their abbreviated names: uracil-5-yl O-sulfamate (SU), 5-thiocyanatouracil (SCNU), and 5-bromouracil (BrU). Arrows indicate bonds possible to break during DEA process. Two DEA possible paths are marked: path A (the bond cleavage between uracil and its substituent) and path B (the bond cleavage within the substituent).
Thermodynamic (ΔG) and Kinetic (ΔG*) Barriers Calculated for DEA Degradation Reactions of Anion Radical Uracil Derivativesa
| thermodynamics, Δ | activation barriers, Δ | ||||||
|---|---|---|---|---|---|---|---|
| substance | degradation path | G2MP2 | M06-2X | B3LYP | G2MP2 | M06-2X | B3LYP |
| SU | C–O (path A) | –12.1 | –7.7 | –12.4 | 11.1 | 10.4 | 11.7 |
| O–S (path B) | –17.4 | –39.4 | –42.6 | 7.5 | 2.3 | 0.96 | |
| SCNU | C–S (path A) | 3.6 | –1.6 | –3.7 | 7.9 | 8.7 | 3.4 |
| S–C (path B) | –12.1 | –16.2 | – | 1.6 | 4.1 | – | |
| BrU | C–Br (path A) | –7.5 | – | –8.0 | 1.8 | – | 2.5 |
All values given in kcal/mol. All calculations conducted with use of the PCM solvation model; for DFT methods 6-31++G(d,p) basis set was used.
Calculated for 1-methyl-5-sulfamateuracil (MeOSOU).
Calculated for 5-thiocyanato-2′-deoxyuridine (SCNdU).[46]
Calculated for 1-methyl-5-thiocyanatouracil (MetSCNU).
Calculated for 5-bromo-1-methyluracil (MetBrU).